Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Elion

Showing results (361-370 of 518) with videos related to

Pageof 52
Sort By:
Blood Cells, Molecules & Diseases|April 13, 2016
Association of adenylyl cyclase 6 rs3730070 polymorphism and hemolytic level in patients with sickle cell anemiaKizzy-Clara Cita, Séverine Ferdinand, Philippe Connes, et al.
Hematology (Amsterdam, Netherlands)|February 24, 2017
Haemoglobin F, A2, and S levels in subjects with or without sickle cell trait in south-eastern GabonLandry-Erik Mombo, Gaël Mabioko-Mbembo, Roland-Fabrice Kassa-Kassa, et al.
Journal of Clinical Microbiology|February 1, 1993
Identification of a clone of Escherichia coli O103:H2 as a potential agent of hemolytic-uremic syndrome in FranceP Mariani-Kurkdjian, E Denamur, A Milon, et al.
Haematologica|February 27, 2001
Rearrangements of the beta-globin gene cluster in apparently typical betaS haplotypesM A Zago, W A Silva, S Gualandro, et al.
Cancer Chemotherapy and Pharmacology|January 1, 1997
Therapeutic efficacy of the topoisomerase I inhibitor 7-ethyl-10-(4-[1-piperidino]-1-piperidino)-carbonyloxy-camptothecin against pediatric and adult central nervous system tumor xenograftsC B Hare, G B Elion, P J Houghton, et al.
Haematologica|February 14, 2013
Fetal hemoglobin and hydroxycarbamide moduate both plasma concentration and cellular origin of circulating microparticles in sickle cell anemia childrenDanitza Nébor, Marc Romana, Raoul Santiago, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|May 18, 2018
Patterns and Correlates of Participant Retention in a Multi-City Pre-Exposure Prophylaxis Demonstration ProjectSusanne Doblecki-Lewis, Albert Y Liu, Daniel J Feaster, et al.
Blood Cells, Molecules & Diseases|September 14, 2010
Strong association between a new marker of hemolysis and glomerulopathy in sickle cell anemiaMicheline Maier-Redelsperger, Pierre Lévy, François Lionnet, et al.
Journal of the American Society of Nephrology : JASN|March 21, 2018
The Most N-Terminal Region of THSD7A Is the Predominant Target for Autoimmunity in THSD7A-Associated Membranous NephropathyLarissa Seifert, Elion Hoxha, Anna M Eichhoff, et al.
British Journal of Cancer|June 1, 1995
Flunarizine enhancement of melphalan activity against drug-sensitive/resistant rhabdomyosarcomaS M Castellino, H S Friedman, G B Elion, et al.
Pageof 52

Showing results (361-370 of 518) with videos related to

Sort By:
Pageof 52
Blood Cells, Molecules & Diseases|April 13, 2016
Association of adenylyl cyclase 6 rs3730070 polymorphism and hemolytic level in patients with sickle cell anemiaKizzy-Clara Cita, Séverine Ferdinand, Philippe Connes, et al.
Hematology (Amsterdam, Netherlands)|February 24, 2017
Haemoglobin F, A2, and S levels in subjects with or without sickle cell trait in south-eastern GabonLandry-Erik Mombo, Gaël Mabioko-Mbembo, Roland-Fabrice Kassa-Kassa, et al.
Journal of Clinical Microbiology|February 1, 1993
Identification of a clone of Escherichia coli O103:H2 as a potential agent of hemolytic-uremic syndrome in FranceP Mariani-Kurkdjian, E Denamur, A Milon, et al.
Haematologica|February 27, 2001
Rearrangements of the beta-globin gene cluster in apparently typical betaS haplotypesM A Zago, W A Silva, S Gualandro, et al.
Cancer Chemotherapy and Pharmacology|January 1, 1997
Therapeutic efficacy of the topoisomerase I inhibitor 7-ethyl-10-(4-[1-piperidino]-1-piperidino)-carbonyloxy-camptothecin against pediatric and adult central nervous system tumor xenograftsC B Hare, G B Elion, P J Houghton, et al.
Haematologica|February 14, 2013
Fetal hemoglobin and hydroxycarbamide moduate both plasma concentration and cellular origin of circulating microparticles in sickle cell anemia childrenDanitza Nébor, Marc Romana, Raoul Santiago, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|May 18, 2018
Patterns and Correlates of Participant Retention in a Multi-City Pre-Exposure Prophylaxis Demonstration ProjectSusanne Doblecki-Lewis, Albert Y Liu, Daniel J Feaster, et al.
Blood Cells, Molecules & Diseases|September 14, 2010
Strong association between a new marker of hemolysis and glomerulopathy in sickle cell anemiaMicheline Maier-Redelsperger, Pierre Lévy, François Lionnet, et al.
Journal of the American Society of Nephrology : JASN|March 21, 2018
The Most N-Terminal Region of THSD7A Is the Predominant Target for Autoimmunity in THSD7A-Associated Membranous NephropathyLarissa Seifert, Elion Hoxha, Anna M Eichhoff, et al.
British Journal of Cancer|June 1, 1995
Flunarizine enhancement of melphalan activity against drug-sensitive/resistant rhabdomyosarcomaS M Castellino, H S Friedman, G B Elion, et al.
Pageof 52